Authors: Thauvin-Robinet, C Maingueneau, C Robert, E Elefant, E Guy, H Caillot, D Casasnovas, RO Douvier, S Nivelon-Chevallier, A

Citation: C. Thauvin-robinet et al., Exposure to hydroxyurea during pregnancy: a case series, LEUKEMIA, 15(8), 2001, pp. 1309-1311

Authors: Ysebaert, L Carli, PM Casasnovas, RO Girodon, F Caillot, D Mugneret, F Maynadie, M

Citation: L. Ysebaert et al., Minimally differentiated acute myeloid leukemia (AML-M0) with lymphoid presentation at relapse: a case report, LEUKEMIA, 15(10), 2001, pp. 1673-1674

Authors: Bene, MC Bernier, M Casasnovas, RO Castoldi, G Doekharan, D van der Holt, B Knapp, W Lemez, P Ludwig, WD Matutes, E Orfao, A Schoch, C Sperling, C van't Veer, MB

Citation: Mc. Bene et al., Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients, BR J HAEM, 113(3), 2001, pp. 737-745

Authors: Solary, E Mannone, L Moreau, D Caillot, D Casasnovas, RO Guy, H Grandjean, M Wolf, JE Andre, F Fenaux, P Canal, P Chauffert, B Wotawa, A Bayssas, M Gennes, P

Citation: E. Solary et al., Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes, LEUKEMIA, 14(12), 2000, pp. 2085-2094

Authors: Casasnovas, RO Haioun, C Dumontet, C Gabarre, J Richard, B Lederlin, P Caillot, D Stamatoullas, A Morel, P Quesnel, B Blay, JY Bouabdallah, K Gisselbrecht, C

Citation: Ro. Casasnovas et al., Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas, HAEMATOLOG, 85(5), 2000, pp. 502-507